Dr Anthony Hama has a Doctor of Pharmacy (PharmD) degree from the Kwame Nkrumah University of Science and Technology (KNUST) in Ghana and an Executive MBA from the Paris Graduate School of Management. He has worked in the Pharma/medical device (IVD and Non-IVD industry) for the past 20 years in Ghana and abroad with managerial positions in Regulatory Affairs, Clinical Trials, Business Development, Project Management, and Marketing. His current role, since January 2022, is the Project Manager at the Navrongo Health Research Centre in Ghana where he is managing the Ghana component of the African Covid-19 Vaccine Safety Surveillance (ACVaSS) in African Advanced Market Commitment -92 eligible countries, a project being sponsored by GAVI and in collaboration with the Global Vaccine Data Network (GVDN) and African Leadership in Vaccinology Expertise (Alive).

Dr. Hama has also served as consultant for several world-class clients in the areas of pre- and post-market regulatory life cycle management in Ghana. He is an expert in pharmacovigilance and product safety.